GSK
Lonza wins contract for Genmab/GSK’s Arzerra
November 12, 2009Manufacturing and Production GSK, Lonza
Swiss contract manufacturer Lonza will manufacture a newly-approved treatment for chronic lymphocytic leukaemia after signing a deal with Genmab and …
GlaxoSmithKline-Pfizer launch HIV joint venture
November 4, 2009Research and Development, Sales and Marketing GSK, HIV, Pfizer, ViiV
GlaxoSmithKline and Pfizer have launched a specialist HIV company with access to ten medicines developed by the two manufacturers.ViiV Healthcare, …
Phase III success for GSK’s lupus drug
November 3, 2009Research and Development, Sales and Marketing Benlysta, GSK
GlaxoSmithKline’s lupus drug Benlysta has been successful in the second of two phase III trials, following earlier performance that exceeded …
GSK returns to growth despite US sales hit
October 28, 2009Sales and Marketing GSK, generics
GlaxoSmithKline suffered a hit in the US during the third quarter of the year, with sales down 12% to £2.14 …
GSK begins phase III COPD trials
October 28, 2009Research and Development, Sales and Marketing COPD, GSK, GlaxoSmithKline, Seretide, Theravance, resp, respiratory
GlaxoSmithKline and San Francisco biopharma firm Theravance have begun a phase III trial to develop a new treatment for chronic …
GSK kidney cancer drug approved in US
October 20, 2009Research and Development, Sales and Marketing Cancer, GSK, rcc
GlaxoSmithKline’s Votrient has been approved in the US by the FDA to treat the most common form of kidney cancer.This …
GSK’s Cervarix finally wins US approval
October 19, 2009Sales and Marketing Cervarix, GSK, US
US regulator the FDA has approved GlaxoSmithKline's cervical cancer vaccine Cervarix, finally allowing the company to bring it to the …
GSK plans
October 14, 2009Research and Development GSK
GlaxoSmithKline, the government and the Wellcome Trust are collaborating to build what they hope will be a "world-class" science park. …
GSK’s Avodart tackles BPH better in combination
October 14, 2009Research and Development, Sales and Marketing GSK, bph, urology
GlaxoSmithKline's urinary treatment Avodart works better as part of a combination therapy, according to a new survey. The drug was …
GSK expands in China with vaccine joint venture
October 12, 2009Sales and Marketing China, GSK, vaccines
GSK has joined with Chinese biotech Jiangsu Walvax to develop and manufacture paediatric vaccines for use in China.The pair will …
Digital Pharma: GSK pushes patient information boundaries
October 12, 2009Medical Communications GSK, digi, digital pharma, patient information
GlaxoSmithKline has launched a product information website for patients in the UK, becoming the second major pharma company to push …
GSK agrees more government orders for H1N1 vaccine
October 7, 2009Sales and Marketing GSK, h1n1, vaccines
GSK has agreed another 22 government orders for its adjuvanted swine-flu vaccine – an extra 149 million doses on top …
GSK: Committed to improving UK clinical research
October 6, 2009Research and Development GSK, GlaxoSmithKline, NHS
GSK is the second biggest pharma company in the world, and Britain’s biggest homegrown firm in the sector. That means …
Europe approves two swine-flu vaccines
September 30, 2009Sales and Marketing EU, GSK, Novartis, h1n1
The European Commission has approved the use of two vaccines for the pandemic H1N1 virus, commonly known as swine flu. …
GSK faces fresh US delays over Cervarix
September 30, 2009Sales and Marketing Cervarix, GSK, vaccines
GSK faces new delays in the US over the approval of its cervical cancer vaccine Cervarix, after the FDA failed …
Latest content
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion
